Raltegravir: is a 400 mg once-daily dose enough?
Lanzafame
Massimiliano
M
Hill
Andrew
A
Lattuada
Emanuela
E
Calcagno
Andrea
A
Bonora
Stefano
S
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D016896:Treatment Outcome; D019562:Viral Load
D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium